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Abstract 
Considering the advantages of gene editing technologies, in recent years, emphasis has been given on three main techniques of 
gene editing i.e. zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the CRISPR/Cas9 
RNA-guided endonuclease system. In all of these three technologies one thing is common i.e. the technology utilizes restriction 
enzymes to break down the double stranded DNA molecule at a targeted location with the help of another molecule of 
homologous binding protein or RNA, which is also called as a guide RNA molecule. This targeted breaking and repair of the 
DNA molecule as per our requirement is generally viewed as a great breakthrough in gene therapy methods. In fisheries sector, in 
order to promote aquaculture/mariculture activities, aquaculture industries are facing number of challenges, particularly in area of 
quality and demand of seed production, control of health and disease management, production of quality traits with 
phenotypically improved varieties, and strengthening of immune system. Several efforts are being made both at public and 
private sectors to develop scientific technologies to meet these challenges and substantial achievements have also been made. But 
still these challenges remained as major constraints in hampering the growth of this industry as per the demand and expectations. 
However, with the advent of now recently developed gene editing techniques, we may have to explore and evaluate the 
possibilities of applications of this technology as a long lasting solution in addressing at least some of the vital issues of the 
aquaculture industry particularly in those related to altering targeted gene structure in the species for positive impact. 
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Introduction  
Fisheries and aquaculture sectors in India are vital sectors of 
food production, providing nutritional security not only to the 
weaker section of the society but also to other classes of 
communities irrespective whether rich or poor and also 
contributing substantially to the total agricultural exports in 
the country. India is the second largest fish producing country 
in the world with the current estimated fish production of 
9.58 million metric tons [1].  With diverse resources ranging 
from deep seas to lakes, reservoirs, rivers, ponds, derelict 
water bodies, floodplains  and more than 10% of the global 
biodiversity in terms of fish and shellfish species, the country 
has shown continuous and sustained increase in fish 
production since independence. Constituting about 6.3% of  
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the global fish production, the sector contributes to 1.1% of 
the GDP and 5.15% of the agricultural GDP. The national 
mean production levels from still-water ponds has gone up 
from about 600 kg/hectare/year in 1974 to over 2900 
kg/hectare/annum at present and several farmers are even 
demonstrating higher production levels of 8–12 
tons/hectare/year. Fish and fish products have presently 
emerged as the largest group in agricultural exports of India, 
with 10.51 lakh tons in terms of quantity and Rs. 33,442 
crores (5.14 b$) in value in 2014-15. This accounts for around 
10% of the total exports of the country and nearly 20% of the 
agricultural exports. More than 50 different types of fish and 
shellfish products are exported to 75 countries around the 
world [1]. 
In order to boost the fish production and maintain the quality 
of the traits, definitely we may have to use modern scientific 
techniques. For past 4-5 decades, several efforts have been 
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made in this direction and the success that has been achieved 
is also limited. There are number of biological issues of the 
aquaculture industry particularly in the area of disease 
control, biotic and abiotic stresses, increase in the growth and 
yield, impact of the environmental factors, etc. which are to 
be addressed using newer powerful technologies. In recent 
years, with the introduction of new genome editing tools such 
as Zinc-finger nucleases (ZFNs), transcription activator like 
effector nucleases (TALENs) and more recently the clustered 
regularly inter-spaced short palindromic repeats (CRISPR)/ 
CRISPR- associated nuclease 9 (Cas9) systems, it has 
become possible to edit gene or knock out undesired part of 
the gene in different animal models [2]. The CRISPR/ Cas9 
system has been introduced as a new class genome 
engineering tool even for those organisms where genome 
editing will be difficult. With this new promising technology 
we may have to think if we can alter the entire scenario of 
fisheries sector particularly that of aquaculture industry which 
is facing number of challenges while growing the aquatic 
animals in captive conditions.  The CRIPSR-Cas technology 
can play an important role in devising molecular tools for 
accelerating reproduction, breeding and spawning, in disease 
control and therapeutics, in developing new traits of quality 
animals, in immune strengthening, and in achieving faster 
growth in captive environment. 
The advantage of using this technology is not to alter or 
replace entire genome which otherwise happens in transgenic 
animals or genetically modified (GM) products, but to change 
or edit the targeted locations of the genome to create positive 
impact of the functional properties. This will result in the 
production of non-GM products which is more acceptable to 
the people and possibly may fit within the frame work of the 
Biotechnology Regulatory Authority of India. Therefore, 
products derived from gene editing could have a relevant 
socio- economic impact and public persecution compared to a 
GM product. 
Biotechnological challenges 
World fish production has reached to approximately 158 
million tons in the year 2014 according to the Food and 
Agriculture Organization (FAO) estimates [3]. Aquaculture 
sector is playing a vital role for increasing fish production all 
over the world. Almost one third of fish consumed today is 
produced from the aquaculture farming. For enhancing the 
production of aquaculture species, new scientific tools are 
being developed and used and the knowledge pertaining to 
the biotechnology is playing  very important role  and has a 
wide range of useful applications particularly in the areas of 
increasing growth and yield of commercial aquaculture 
species, for improving genetic traits with desired 
characteristics, strengthening immune system, fish health and 
disease management, boosting the nutritional value of aqua 
feed, restoring and protection of the environment, 
diversification of species, and conservation measure of the 
wild stocks. Some biotechnological tools are traditional and 
developed based on indigenous technical knowhow while 
others are more advanced based on the new discoveries of 
research in molecular biology and genetic engineering. In the 
field of genetic biotechnology, simple technique like 
hybridization to more advanced technique such as the transfer 
of specific genes between species to create Genetically 
Modified Organisms (GMOs) are being commonly used [4]. 
But now with the advent of new technique of gene editing, 
there is a possibility of creating new trait of species with 
desired properties without replacing the whole genome.   
Biotechnology research as on today has the capability to 
address number of issues not only related to the aquaculture 
farming but also those concerning with the environment. In 
the semi-intensive and intensive fish culture systems, one of 
the major concerns is the source of protein used in the 
preparation of fish diet. The source of protein is generally 
from the fish meal as this contains high amount of animal 
protein. Fish meal manufacturing industries depends up on 
trash fish/low value fish as raw material for the preparation of 
fish meal. The processing cost of fish meal production is 
always high and not economical to the fish farmers. 
Therefore, there is a need to find out the alternate source of 
cheaper protein which can be used in the fish diet [4]. 
Another concern of fish meal production is continuous supply 
of raw material to the manufacturing units in the form of trash 
fish from the wild stock as per the demand of fish meal 
producers and also stability in the production. Due to an 
increase in wild fish catch all over the world, the world fish 
stocks are declining day by day resulting in the non-
availability of continuous supply of trash fish and reduction 
in fish meal production. Moreover, the use of fish meal in the 
fish diet creates environmental problems in the fish farming 
system. The fish meal contains high amount of phosphorus 
which leaches out in the pond water that leads to the 
formation of algal bloom and eutrophication affecting the fish 
culture system [4]. As a result of these concerns with fish 
meal, researchers are using biotechnology to produce 
alternative plant-based protein source [5]. In an effort to find 
out the alternate source of protein, number of workers has 
diverted their focus of research to derive protein from the 
plant sources. Though plant proteins may address the problem 
of phosphorus content in the fish meal but there can be 
possibility of the presence of other ingredients in plant 
proteins which may create hurdles in the fish diet. It has been 
reported that there are number of anti-nutritional compounds 
present in plant proteins [4]. Such compounds one has to 
evaluate and find out for their elimination by intervention of 
biotechnological tools. Now the recent focus of research is on 
introducing some enzymes (phytase) in the fish diet which 
can act as anti-nutritional factors. The enzyme phytase can 
help fish to make the best use of the phosphorus available in 
plant protein based feed [4]. 
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Madany et al. (1996) while working on trace metals 
concentrations in marine organisms reported that the farmed 
aquatic animals are very sensitive to the various 
environmental factors and will have to depend mainly on 
oxygen and other organic and inorganic compounds for their 
survival and growth. While inhabiting in such environment 
they also absorb and carry other wastes from nearby 
environment. There is a possibility of disease outbreak in this 
kind of environment which may result in mass mortality of 
fish [6]. Verschuere et al. (2000) reported that removal of 
pollutants from the aquatic environment can be done by using 
the technique of bioremediation. They further mentioned that 
either scavenging bacteria or novel probiotics can be 
developed and used for controlling in the aquaculture system 
[7]. Researchers are making continuous efforts to improve the 
genetic traits of the fish using various genetic engineering 
techniques. Efforts are also being made to produce fish which 
can grow faster, efficient in feed conversion in to body mass, 
resistance to diseases, and tolerant to various biotic and 
abiotic stresses. Number of workers have developed 
genetically improved tilapia for commercial aquaculture 
through selective breeding technique [8-11]. However, there 
is a restriction to the exploitation of Tilapia in developing 
countries due to the limited growth rate and excessive 
reproduction which results in fish that are small and variable 
in size. Transgenic techniques offer the means of producing 
the traits with targeted desired properties [9, 11]. However, 
ethical issues are yet to be addressed as far as transgenic fish 
is concerned. 
In recent years, aquaculture and marine biotechnology is 
gaining lot of importance not only from the food security 
point of view but also due to its substantial contribution to 
our economy through the development of biotechnology 
industry. Billions of people all over the world are dependent 
on aquatic and marine biodiversity for their livelihood, day to 
day income generation, and employment opportunities. 
Biotechnology related to aquaculture and marine sciences can 
address number of future challenges particularly in the area of 
discovery of new products and processes of economic 
importance through rich biodiversity that is available in our 
seas and oceans in particular. At present continuous efforts 
are being made to exploit these resources on sustainable basis 
for their effective and judicious use as health food, in the field 
of pharmaceutical and nutraceutical industries, and in 
production of medicines and biomaterials. Recent research 
indicates that the marine biotechnology is now being heavily 
used to find out the alternate source of energies in the form of 
biofuels from the micro-organisms (micro-algae). The 
potential for the growth of marine biotechnology is, therefore, 
even more relevant now than it was in the past and a sound 
strategy for its development in India is being addressed to 
allow this potential to be realized and harnessed. Thus, 
Marine Biotechnology is capable of making inroads and 
important contribution towards meeting impending 
challenges in food production, energy, environment and 
human health sector [12]. 
In marine biotechnology, the domain areas of research that 
have been identified are disease diagnostics, vaccine 
development and immune-stimulant research along with the 
discovery of biomolecules that have anti-bacterial, anti-
inflammatory, and anti-cancer properties. The research 
carried out so far in the development of suitable fish and 
shellfish cell lines and tissue culture systems will create the 
much needed support to enhance diagnosis of aquatic animal 
viruses and could lead to large scale production of vaccines. 
The gene mapping and development of molecular diagnostic 
methods of some shrimp viruses have been successfully 
carried out to address issues of biosecurity and manage 
disease problems by preventing their spread in aquaculture 
farms [12]. This has also facilitated the development of novel 
sensitive and specific DNA and antibody based diagnostics 
for the various fish, prawn and shrimp diseases. Recombinant 
protein vaccines developed for warm water fish pathogens 
such as Aeromonas hydrophila, Edwardsiella tarda, and 
Vibrio anguillarum have shown enhanced immune response 
and a high degree of protection against disease in laboratory 
trials and these products are ready for field trials. Viral 
vaccine for the dreaded nodavirus disease of Seabass, has 
shown promise in managing the associated mortalities in 
hatcheries. Since biotechnological approaches in aquaculture 
is expected to provide food security by enhancing production 
and reducing losses due to diseases, considerable research has 
been done into improving production by basic studies on 
breeding technologies, species diversification, developing 
genetically resistant stocks, transgenic approach to develop 
resistant and fast growing varieties, and development of 
appropriate feeds and feeding regimes including larval feeds 
[12]. Research is being carried out with regard to the 
utilization of waste materials such as chitinous shell of 
crustacean and collagen of fish for production of novel 
biomaterials with diverse applications [13, 14]. Research on 
marine derived biomaterials and molecules such as microbial 
enzymes and bio products that find application to human and 
animal health has also been prioritized through various 
funding agencies. Successful isolation of deep-sea fungi and 
other extremophiles, the cloning and expression of novel 
enzymes from them has resulted in promising technologies. 
To promote aquaculture of marine species, we need powerful 
technologies for accelerating maturation and growth process 
in fish and shellfish in captive condition. Eyestalk ablation 
technique for breeding and spawning of shrimp and prawns 
need to be replaced with an alternate technology based on 
molecular biology. This powerful technique may pave the 
way for regular breeding and spawning of commercial 
shrimps in captive condition and our requirement of 
enormous amount of seed can be fulfilled. 
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Gene editing technology 
Gene editing technology is gaining lot of importance in recent 
years to improve the quality of traits particularly in the 
agricultural commodities, animal and fisheries sector, etc. 
Researchers have focused on the application of three main 
types of gene editing techniques viz., ZFNs, TALENs, and 
the CRISPR/Cas9 RNA-guided endonuclease system. Each of 
these technologies utilizes restriction enzymes to introduce a 
DNA double stranded break at a targeted location with the 
guide of homologous binding proteins or RNA. Such 
targeting location and altering the defective portion of the 
gene structure is viewed as a significant advancement in 
genetic engineering when compared to current gene therapy 
methods that lack such specificity. In recent years, 
researchers have conducted several studies to evaluate gene 
editing tool using various experimental animals to treat 
multiple disorders related genetic defects including in vivo 
experiments in mammals and even early phase human trials 
[15-17].  
CRISPR like concept was first discovered by the Japanese 
scientist while working on the DNA of bacteria in 1987 [18]. 
While working on protein-encoding gene in E.coli, they 
found a pattern of short, repeating, palindromic DNA 
sequences separated by short, non-repeating, “spacer” DNA 
sequences in the whole genome structure. Later, they reported 
that these repeats were present in many bacteria and other 
single-celled organisms. Jinek et al. (2012) while studying the 
RNA guided DNA endonucleases in adaptive bacterial 
immunity introduced the term ‘CRISPR’ to describe the 
pattern of DNA configuration in the bacterial genome. 
Further, while studying the CRISPR in details they 
discovered that the repeating DNA patterns, along with a 
family of “Cas” (CRISPR-associated) proteins and 
specialized RNA molecules, play a significant role in 
bacterial immune systems [19].  
Concept of CRISPR was developed earlier by researchers 
while studying the bacterial immune system and adoption of 
defence mechanism in response to invading DNA molecule in 
the form of virus. Upon analysis of the bacterial immunity, it 
was observed that in response to invading DNA of the virus, 
CRISPR-Cas can copy the segments of foreign DNA 
molecule and incorporate the same in to their genome as 
“spacers” between the short DNA repeats in the form of 
CRISPR. These copied DNA molecules in the spacers 
actually protects the bacteria by strengthening their immune 
system by providing RNA molecule in the template form and 
identify and target quickly the same DNA molecule in the 
event of future viral infection. If these template RNA 
molecules identifies the incoming foreign DNA, then these 
template RNAs actually guide the CRISPR complex to that 
sequence. Further, the Cas protein that is present in the 
bacteria has the unique property of cutting DNA molecule 
and disabling the foreign invading DNA. From these 
important findings of the bacterial immune system reported 
by number of earlier workers [18], Doudna and Charpentier 
(2014) developed a technique of gene editing [20]. Later they 
named this technique as CRISPR-Cas technology [17, 19]. 
This technology involved CRISPR, a Cas protein called Cas9, 
and hybrid RNA that could be programmed to identify, cut, 
and even replace any gene sequence. The main advantage of 
the CRISPR technology over the other two gene editing 
technologies namely, ZFNs and TALENS is that the 
technology is cost effective and user-friendly. In ZFNs and 
TALENS technologies, there is a need of custom proteins for 
each targeted DNA molecule. As far as CRISPR-Cas9 
technology is concerned, there are several reports regarding 
its successful usage in the embryos of mice, frogs, and 
monkeys, human stem cells, and immune cells. There are also 
published reports regarding exploration of different 
applications of CRISPR-Cas9 in genetically modifying 
agricultural crops, eradicating of viruses and screening of 
cancer genes. Doudna and Charpentier (2014) while working 
on genome engineering with CRISPR-Cas9 mentioned that 
there are number of techniques available to reduce the 
number of mutations at unintended sites in the animal system 
[20]. Now with advent of genome engineering technologies 
like CRISPR-Cas9, it is possible to intervene in the human 
genome function very precisely by editing undesired portion 
of DNA sequence. Here, the Cas9 can be guided to the 
targeted locations within the genome complex by a short 
RNA molecule. In recent times, several researchers have 
described that with this CRISPR-Cas9 technology, one can 
edit the DNA sequences within the endogenous genome and 
change the functional output virtually in any organism [2, 
17]. 
Makarova et al. (2011) while working on the evolution and 
classification of the CRISPR-Cas systems reported three 
types of CRISPR mechanisms i.e. type I, type II and type III, 
each of which is characterized by signature proteins (Cas3, 
Cas9 or Cas10) [21]. Further it is mentioned that out of three 
types of CRISPR mechanisms, type II is the most studied one. 
Jinek et al. (2012, 2013) and Doudna and Charpentier (2014) 
while working on dual-RNA–guided DNA endonuclease in 
adaptive bacterial immunity mentioned the detailed 
mechanism of type-II CRISPR. In this mechanism they found 
out that when foreign DNA from viruses or plasmids invades 
in to the bacteria, this DNA molecule is immediately broken 
in to small fragments and get incorporated in to the targeted 
locus as short repeats. These loci are later transcribed and 
then the transcripts are processed to generate small RNAs 
(crRNA) which are used to guide effector endonucleases that 
target invading DNA based on sequence complementarity. To 
achieve site specific DNA recognition, Cas9 must be 
complexed with both a crRNA and a separate transactivating 
crRNA that is partially complimentary to crRNA [17, 19, 20]. 
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In fisheries sector, in order to promote 
aquaculture/mariculture activities, industries related to this 
field are facing number of challenges as mentioned above, 
particularly in area of seed production as per the requirement, 
control of health and hygiene, production of quality traits 
with phenotypically improved varieties, and strengthening 
immune system. Several efforts are being made to develop 
techniques based on biotechnological knowledge or 
molecular genomics to meet these challenges and substantial 
achievements have also been made. However, with the advent 
of now recently developed gene editing technique, we may 
have to evaluate the possibilities of applications of this 
technology in addressing at least some of the important issues 
in the above mentioned areas. In shrimps and prawns, there 
are supressing/inhibiting factors in the eyestalk 
neuroendocrine complex which always prevents breeding and 
spawning in captive condition. Even the growth process is 
also hampered by these inhibiting factors. The immune 
system of these animals has been reported to be fragile and 
therefore, the chances of occurrences of viral and bacterial 
diseases are very common. Heavy losses have been reported 
by the shrimp or aquaculture industries due to the outbreak of 
diseases. Gene structure of gonad inhibiting hormone (GIH) 
and moult inhibiting hormone (MIH) in case of certain 
marine shrimps has already been investigated [22-24]. This 
structure of the gene can be altered/edited by using CRISPR-
Cas technology to eliminate the negative impact of these 
hormones on reproduction and growth processes. This may 
pave the way to develop an alternative and powerful 
technique in place of eyestalk ablation with similar impact. 
Efforts have been made to silence/knockout this gene using 
the technique of RNA interference by some workers but the 
success achieved is not as per the expectations and further 
research is needed in this area [25, 26]. Treerattrakool et al. 
(2011) while working on P. monodon used the technique of 
RNA interference for inducement of maturation both in wild 
and captive shrimp and reported that shrimps injected with 
anti-GIH double stranded (ds) RNA showed advanced 
maturation [25]. Das et al. (2015) reported silencing of gonad 
inhibiting hormone gene in the eyestalk neuroendocrine 
complex of the tiger shrimp P. monodon by using the 
technique of RNA interference. They observed 3–5 fold 
enhanced expression of the androgenic gland hormone 
(AGH) transcript in males, but there was no effect on 
vitellogenin expression in females. In the destalked animals, 
however, positive effect on the maturation indicator 
transcripts was seen in both the sexes, and surpassed the 
efficiency of the silencing treatment [26]. 
The rapid advances being made in gene editing using the 
CRISPR-Cas9 system have led to increasing interest in the 
application of this technology in zebra fish embryos for gene 
knockout. Blasky et al. demonstrated that by using CRISPR-
Cas9 in the embryos of zebra fish through microinjection, it is 
possible to knockout the functional protein gene by gene 
editing efficiency.  To determine the efficacy of the Edit-R 
CRISPR-Cas9 in zebra fish, approximately 100 single-cell 
stage embryos were microinjected with Cas9 mRNA and 
synthetic cr-RNA, tracr-RNA, and approximately 50 control 
embryos were injected with Cas9 mRNA only. High survival 
rate of embryos after injection was observed (above 95%). 
Detecting functional knockout of Green Fluorescent Protein 
(GFP) was performed by imaging the zebra fish microinjected 
with Cas9 mRNA and crRNA, tracrRNA and comparing 
them to the embryos that were not injected. Following 
microinjection of CRISPR-Cas9 components targeting GFP, a 
loss or decrease in GFP fluorescence is observed in the zebra 
fish embryo, confirming successful gene knockout [27]. 
CRISPR-Cas technology can also be used to control the viral 
and bacterial diseases particularly in shrimps and prawns. The 
mechanism of CRISPR-Cas in shrimps/prawns may also 
work just like that of bacteria when they are invaded by virus 
DNA. For example, when WSSV invades shrimps, CRISPR-
Cas can copy and incorporate segments of the WSSV DNA 
into their genome as “spacers” between the short DNA 
repeats in CRISPR. These spacers enhance the shrimp’s 
immune response by providing a template for RNA molecules 
to quickly identify and target the same DNA sequence in the 
event of future viral infections. If the RNA molecules 
recognize an incoming sequence of foreign DNA, they guide 
the CRISPR complex to that sequence. There, the shrimp’s 
Cas proteins, which are specialized for cutting DNA, splice 
and disable the invading gene. This may result in protecting 
the shrimp from infectious diseases. Therefore, a modern 
genome editing CRISPR- Cas9 technology can prove as a 
powerful tool in order to prevent the infection of viral and 
bacterial pathogens. CRISPR has potential of altering germ 
line of humans, animals, and other organisms. This approach 
can be achieved with the help of supporting tools like 
bioinformatics, primer design, and microinjection to identify 
and insert the CRISPR-Cas9 into the targeted genome. 
More recently, the CRISPR-Cas9 system has greatly 
expanded the ability to knock-out genes in different animal 
models, including zebrafish [28, 29]. However, time and costs 
required for the screening of a huge number of animals are 
still a bottleneck. In fish, breeding and spawning in captive 
condition at our desired time is still not that easy. In 
advancing maturation by using hormonal techniques, limited 
success has been achieved. In such situations, is it possible to 
use CRIPSR–Cas technique to edit genes responsible to 
produce gonad stimulating hormones at desired time and 
maintain its hormonal titre in the body on continuous basis so 
that maturation process will be faster is a matter of 
investigation. Even the possibility to eliminate the knock-out 
of the undesired genes not favoring gonad development by 
using the CRISPR-Cas technique has to be investigated. Fish 
and shellfishes are very sensitive animals and are susceptible 
for infectious diseases. The common infectious vectors are 
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viruses, bacteria, fungi, and parasites. In fish farming systems 
occurrence of such infectious diseases is common affair 
which generally affects the growth and development of 
aquatic species. However, if the infections are of severe 
nature or in the event of outbreak of disease, there can be 
huge mortality and the whole farming operations may 
collapse. Therefore, controlling of diseases is one of the most 
vital tasks in fish culture system. Several methods are being 
developed and used including the fish vaccines to control the 
various diseases. But still whenever outbreak of disease 
occurs, heavy losses have been reported by the aquaculture 
industry. Therefore, we need to have powerful tools like gene 
editing using CRISPR-Cas technology to control the diseases 
particularly those which are caused by viral and bacterial 
infections. Recently, Brown et al. (2016) while working on 
multiplexed targeted genome engineering technology using 
nuclease assisted vector integration system reported that with 
the help of this technology one can knock out selected or 
targeted gene of the vector thereby minimizing the cost and 
time frame needed for gene editing. It has also been  
mentioned that this system is capable of remodeling native 
mammalian genome through DNA integration, up to 50kb, 
facilitating quick generation and screening of multigene 
knockouts from a single transfection. Furthermore, they have 
mentioned that this nuclease-assisted vector integration is a 
very strong tool for gene editing that will facilitate diverse 
application in gene therapy and synthetic biology [30]. 
In CRISPR system, gene knock out is carried out by 
introducing DNA double strand breaks (DSB) at the target 
locus and when these are repaired by error- prone DNA repair 
pathways, it causes inactivating mutations. It is reported that 
this system is laborious and costly for identification and 
isolation of isogenic cell lines which remains challenging in 
genetic engineering. Whereas in the case of multiplexed 
targeted genome engineering tool, there is mechanism of co-
delivering engineered nucleases with donor vector containing 
expression cassettes that confer antibiotic resistance for rapid 
clonal screening. These donor vectors consists of two DNA 
sequences homologous to the region of DNA upstream and 
downstream of the intended DNA double strand break, 
flanking the heterogeneous DNA that will be incorporated 
into the genome following repair of DSB. Here, the donor 
vector stimulates DNA repair through homologous 
recombination pathway [31]. This method has been used 
successfully for multiple applications [32] including gene 
knock out, delivery of therapeutic genes [15, 33] or for 
tagging endogenous proteins [34-36].  
Conclusion 
The Biotechnological challenges as far as aquaculture 
industry is concerned are many. The growth of the industry is 
not progressing as expected due to the lack of powerful 
scientific tools to control many factors at the farm level while 
culturing the commercial species in the aquatic environment. 
Heavy losses have been reported every year due to mass 
mortality, rejecting the consignment of aquaculture species 
attributed to lack of quality standards, biotic and abiotic 
stresses impact on aquaculture species, and no standard 
methods/protocols for disease control and pollution impact. 
Several attempts have been made using the knowledge of 
biotechnology to solve some of the problems of the 
aquaculture industry. However, at this juncture we need very 
powerful technologies to mitigate some of the severe issues 
that the aquaculture industry is facing. With the advent of the 
discovery of CRISPR Cas technology, there is a possibility 
that those biological issues related genetic disorders or 
otherwise can be solved safely without much altering the 
genetic structure of the aquaculture species. 
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